Tuberculosis Vaccine Linked to Lower COVID-19 Mortality Rates, Preliminary Study Finds | WHAT REALLY HAPPENED

Tuberculosis Vaccine Linked to Lower COVID-19 Mortality Rates, Preliminary Study Finds

A preliminary study set to soon be published in the Proceedings of the National Academy of Sciences journal suggests that a century-old tuberculosis vaccine may play a role in decreasing COVID-19 mortality rates.

The research, conducted by Assistant Professor Luis Escobar of Virginia Tech’s College of Natural Resources and Environment and two officials at the US National Institutes of Health, sought to uncover why developing countries, including some Latin American ones, are seeing lower COVID-19 mortality rates than several US states.

“This is remarkable, considering that [these parts of] Latin America have much higher population densities than the North American states analysed, including New York,” co-author Carolina Barillas-Mury wrote in the peer-reviewed paper.

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA